FILE:AMGN/AMGN-8K-20050131142039.txt.gz
EVENTS:	Other Events	Financial Statements and Exhibits
TEXT:
ITEM: Other Events
ITEM: Financial Statements and Exhibits
 
Check the appropriate box if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
 
Item 8.01. Other Events
Amgen Inc. announced on January 31, 2005 that it has filed a Tender Offer Statement on Schedule TO-I with the Securities and Exchange Commission relating to the obligation of Amgen to purchase its Liquid Yield Option Notes due 2032 (Zero Coupon  Senior) (the ""), at a purchase price of $738.68 per $1,000 principal amount at maturity outstanding, at the option of the holders thereof. Holders of the LYONs have the right to surrender their LYONs for purchase commencing on that date. The opportunity to surrender LYONS for purchase will terminate at 5:00 p.m., New York City time, on March 1, 2005, as more fully described in the Company's Schedule TO-I.
LYONs
Item 9.01. Financial Statements and Exhibits
 
     Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 


